You just read:

Research and Markets - Frontier Pharma Report: Head and Neck Cancer Market 2017 - Immunotherapies and Signal Transduction Inhibitors Dominate First-in-Class Innovation

News provided by

Research and Markets

Apr 07, 2017, 16:30 ET